CW August 2006Issue Number 8 August 2006 ISSN 10593802 Stimulating Killer Cell Activity Might Assist Breast Cancer DrugInterleukin-21, which stimulates natural killer cells to secrete interferon gamma, may enhance the antitumor effect of Herceptin, the monoclonal antibody used to treat HER2-positive breast cancer.
Go to Previous Page Go to Next Page Source & Additional Reading William E. Carson, III, online edition of Journal of immunology, July 1, 2006. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW August 2006Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |